$ALAB
Astera Labs, Inc.
CIK:0001736297|SEC Filings
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 392,400 | $ 191,925 | $ 700,761 | $ 351,367 |
| Cost of revenue | 104,833 | 46,362 | 178,053 | 86,393 |
| Gross profit | 287,567 | 145,563 | 522,708 | 264,974 |
| Operating expenses | ||||
| Research and development | 135,898 | 66,724 | 261,532 | 131,278 |
| Sales and marketing | 26,372 | 18,609 | 48,271 | 40,311 |
| General and administrative | 36,049 | 20,456 | 61,824 | 42,326 |
| Total operating expenses | 198,319 | 105,789 | 371,627 | 213,915 |
| Operating income | 89,248 | 39,774 | 151,081 | 51,059 |
| Interest and other income | 13,577 | 10,885 | 25,158 | 21,317 |
| Income before income taxes | 102,825 | 50,659 | 176,239 | 72,376 |
| Income tax benefit | 50,263 | 560 | 57,159 | 10,662 |
| Net income | $ 153,088 | $ 51,219 | $ 233,398 | $ 83,038 |
| Net income per share attributable to common stockholders: | ||||
| Basic (in dollars per share) | $ 0.89 | $ 0.31 | $ 1.36 | $ 0.51 |
| Diluted (in dollars per share) | $ 0.83 | $ 0.29 | $ 1.28 | $ 0.47 |
| Weighted-average shares used in calculating net income per share attributable to common stockholders: | ||||
| Basic (in shares) | 172,378 | 165,428 | 171,557 | 164,316 |
| Diluted (in shares) | 183,340 | 178,100 | 182,254 | 178,281 |
| Other comprehensive (loss) income | ||||
| Unrealized (loss) gain on marketable securities, net of taxes | $ (2,589) | $ 846 | $ (7,679) | $ 2,448 |
| Total other comprehensive (loss) gain | (2,589) | 846 | (7,679) | 2,448 |
| Total comprehensive income | $ 150,499 | $ 52,065 | $ 225,719 | $ 85,486 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | $ 111,453 | $ 167,611 |
| Marketable securities | 1,141,505 | 1,021,205 |
| Accounts receivable, net | 192,469 | 83,202 |
| Inventory | 113,781 | 58,979 |
| Prepaid expenses and other current assets | 92,687 | 31,033 |
| Total current assets | 1,651,895 | 1,362,030 |
| Property and equipment, net | 119,284 | 92,038 |
| Goodwill | 91,557 | 19,015 |
| Other assets | 68,765 | 58,740 |
| Total assets | 1,931,501 | 1,531,823 |
| Current liabilities | ||
| Accounts payable | 53,930 | 42,362 |
| Accrued expenses and other current liabilities | 110,377 | 90,680 |
| Total current liabilities | 164,307 | 133,042 |
| Other liabilities | 41,490 | 35,147 |
| Total liabilities | 205,797 | 168,189 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity | ||
| Common stock, $0.0001 par value; 1,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 173,485 and 170,186 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 17 | 17 |
| Additional paid-in capital | 1,485,320 | 1,348,969 |
| Accumulated other comprehensive (loss) income | (3,369) | 4,310 |
| Retained earnings | 243,736 | 10,338 |
| Total stockholders’ equity | 1,725,704 | 1,363,634 |
| Total liabilities and stockholders’ equity | $ 1,931,501 | $ 1,531,823 |